Lipoxygenases - A Challenging Problem in Enzyme Inhibition and Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-6662|3|2|119-132

ISSN： 1573-4080

Source： Current Enzyme Inhibition, Vol.3, Iss.2, 2007-05, pp. : 119-132

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

UDP-Gal: GlcNAc-R β1,4-galactosyltransferase—a target enzyme for drug design. Acceptor specificity and inhibition of the enzyme

By Brockhausen Inka   Benn Melinda   Bhat Shridhar   Marone Sandra   Riley John   Montoya-Peleaz Pedro   Vlahakis Jason   Paulsen Hans   Schutzbach John   Szarek Walter  

Glycoconjugate Journal, Vol. 23, Iss. 7-8, 2006-11 ,pp. : 525-541

Springer Publishing Company

Access to resources Recommend Favorite

Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans

By Kanazu T.   Yamaguchi Y.   Okamura N.   Baba T.   Koike M.  

Xenobiotica, Vol. 34, Iss. 5, 2004-05 ,pp. : 391-402

Informa Healthcare

Access to resources Recommend Favorite

Model for the drug-drug interaction responsible for CYP3A enzyme inhibition. II: establishment and evaluation of dexamethasone-pretreated female rats

By Kanazu T.   Yamaguchi Y.   Okamura N.   Baba T.   Koike M.  

Xenobiotica, Vol. 34, Iss. 5, 2004-05 ,pp. : 403-413

Informa Healthcare

Access to resources Recommend Favorite

Implications and consequences of enzyme induction on preclinical and clinical drug development

By Worboys P. D.   Carlile D. J.  

Xenobiotica, Vol. 31, Iss. 8-9, 2001-08 ,pp. : 539-556

Informa Healthcare

Access to resources Recommend Favorite

Enzyme Inhibition by Usnic Acids

By  

Current Enzyme Inhibition, Vol. 4, Iss. 4, 2008-12 ,pp. : 180-185

Bentham Science Publishers

Access to resources Recommend Favorite